ID2 and invasive breast carcinoma: Using a clinical breast cancer tissue microarray (TMA), we analyzed subcellular distribution of Id2 in 148 invasive breast cancers and observe that ILC cases more often display cytosolic Id2 localization compared to IDC-NST (Fig. 7C, p = 0.0004).